<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Lithuania</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Lithuania.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/lt.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Cognitive outcome in relation to cerebrospinal fluid markers of neuronal and glial cell damage: A prospective study of tick-borne encephalitis.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ttbdis-2026-102673-9fdde805/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ttbdis-2026-102673-9fdde805/</guid>
    <pubDate>Thu, 18 Jun 2026 00:00:00 GMT</pubDate>
    <description>Findings suggest that an acute-phase glial biomarker in CSF may help identify tick-borne encephalitis patients at risk of persistent cognitive deficits, which is relevant given the frequency of long-term cognitive sequelae reported in this cohort.</description>
    <category>Tick-borne encephalitis</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-05-022-97a8b288/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-05-022-97a8b288/</guid>
    <pubDate>Fri, 01 Jul 2022 00:00:00 GMT</pubDate>
    <description>The registry addresses a recognized barrier in pandemic response by providing a centralized infrastructure to accelerate clinical trial recruitment across European countries, potentially shortening the timeline for vaccine and treatment development during infectious disease outbreaks.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
